Publication

Video

Sponsored

Honeywell and the Future of Life Sciences Manufacturing

Author(s):

Honeywell
Conference|INTERPHEX

Shawn Opatka, Vice President & General Manager of Life Sciences at Honeywell, discusses how the company stands out in an industry that constantly evolves.

To learn more about manufacturing in the life sciences industry, Pharmaceutical Technology sat down with Shawn Opatka, Vice President & General Manager of Life Sciences at Honeywell, at a recent INTERPHEX conference to discuss:

  • How automation technologies will likely evolve;
  • How Honeywell helps meet current industry challenges while maintaining an eye on the future;
  • What differentiates Honeywell from the competition in its approach to manufacturing and digitalization.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
US tariff rate rising , trade policy , business graph and dollars banknote , tax calculation change | Image Credit: © janews094 - stock.adobe.com
Related Content
A lab technician in protective gear operates a tablet displaying a green checkmark in a high-tech pharmaceutical laboratory. | Image Credit: © greenbutterfly - stock.adobe.com
May 29th 2025

Companies Reveal Their Next Moves in Manufacturing

Patrick Lavery
In discussions at INTERPHEX 2025, company representatives seized upon several common themes, most notably safety, sustainability, and the increasing utility of automation.
A doctor in a white lab coat shaking hand showing symbol of medicine innovation, treatment, discovery and healthcare analysis. | Image Credit: © chadchai - stock.adobe.com
May 28th 2025

Geopolitical Shifts Change Nature of Pharma Partnerships

Patrick Lavery
The concerns of industry experts expressed at INTERPHEX in April 2025 are still pertinent in an uncertain global political climate.
The show floor at INTERPHEX 2025. | Image Credit: © Patrick Lavery/PharmTech Group
April 4th 2025

Recapping INTERPHEX 2025: Pharma Looks Toward the Future

Patrick Lavery
The yearly convention in New York City showcased new and emerging technologies and gave participating exhibitors a chance to unveil their strategies for the second half of the 2020s.
drug manufacturing
April 3rd 2025

Pharma 4.0: What are Industry Leaders Prioritizing in the Modernization of Pharmaceutical Manufacturing?

Alicia Bigica
The move towards “pharma 4.0” requires a major shift, both ideologically and technologically, to adapt current processes to a framework that will automate much of today’s manufacturing.
INTERPHEX 2025: Industry Initiates Interchangeable Single-Use Assembly Components in Response to COVID-19 Supply-Chain Disruption
April 3rd 2025

INTERPHEX 2025: Industry Initiates Interchangeable Single-Use Assembly Components in Response to COVID-19 Supply-Chain Disruption

Patrick Lavery Feliza Mirasol
Sitting down with the PharmTech Group at INTERPHEX 2025, Nicole Hunter, head of Global WMArchitect at WMFTS, explains the industry initiative around single-use assembly components resulting from supply disruptions caused by the COVID-19 pandemic.
INTERPHEX 2025: Innovations in Advanced Sensing Technologies that Answer the Need for Reliable Valve Function
April 3rd 2025

INTERPHEX 2025: Innovations in Advanced Sensing Technologies that Answer the Need for Reliable Valve Function

Patrick Lavery Feliza Mirasol
Speaking with the PharmTech Group at INTERPHEX 2025, Dave Loula, global product director, ITT Engineered Valves, discusses innovation in advanced sensing technologies that addresses customer need for reliable valve function.